Cognition Therapeutics's total assets for Q4 2025 were $48.39M, an increase of 11.51% from the previous quarter. CGTX total liabilities were $14.12M for the fiscal quarter, a 105.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.